ClinicalTrials.gov · NCT04733534 · Active, not recruiting
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
Registry record
NCT04733534 on ClinicalTrials.gov. The registry's last update to this record was 30 September 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor St. Jude Children's Research Hospital Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Dasatinib plus Quercetin; Fisetin Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in walking speed | Change in Walking Speed | Change in Walking Speed | Change in Walking Speed | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Active, not recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-09-30. Checked
Check history: NCT04733534 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: St. Jude Children's Research Hospital
- Phase: Phase 2
- Status: Active, not recruiting
- Intervention: Dasatinib plus Quercetin; Fisetin
- Primary outcome: Change in walking speed | Change in Walking Speed | Change in Walking Speed | Change in Walking Speed | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A) | Senescent cell abundance in blood (p16INK4A)
- Countries: United States
- Start: 6 June 2022
- Completion (estimated): December 2027
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.
Related modality